量子ドット自発光ディスプレイの未来を探る！2026年QDELセミナー開催 2026年4月21日に開催されるセミナーでは、沖本真也氏がQDELに関する最新の市場動向や技術課題を解説。皆様のビジネス戦略に役立つ情報満載です。

量子ドット自発光ディスプレイの未来を探る！2026年QDELセミナー開催 #ディスプレイ #QDEL #量子ドット

2026年4月21日に開催されるセミナーでは、沖本真也氏がQDELに関する最新の市場動向や技術課題を解説。皆様のビジネス戦略に役立つ情報満載です。

2026年、次世代ディスプレイ「QDEL」の市場動向を解説するセミナー開催 2026年4月21日、次世代ディスプレイQDELに関するセミナーが沖本氏を講師に開催。市場動向や技術の進展を詳しく解説します。

2026年、次世代ディスプレイ「QDEL」の市場動向を解説するセミナー開催 #沖為工作室 #ディスプレイ #QDEL

2026年4月21日、次世代ディスプレイQDELに関するセミナーが沖本氏を講師に開催。市場動向や技術の進展を詳しく解説します。

QuidelOrtho's Q3 2025 Financial Results: Key Highlights and Future Outlook QuidelOrtho's third quarter financial report reveals a total revenue of $700 million, showcasing mid-single digit growth, excluding COVID-19 impacts.

QuidelOrtho's Q3 2025 Financial Results: Key Highlights and Future Outlook #United_States #San_Diego #diagnostics #QuidelOrtho #QDEL

QuidelOrtho Reports Third Quarter 2025 Financial Results QuidelOrtho (Nasdaq: QDEL) reported Q3 2025 total revenue of $700 million and an adjusted diluted EPS of $0.80. GAAP results included a $701 million non-cash goodwill impairmentGAAP net loss of $733 million and GAAP diluted loss per share of $10.78. Adjusted EBITDA was $177 million with a 25% margin. The company completed a debt refinancing to improve financial flexibility and narrowed full-year 2025 guidance to $2.68–$2.74 billion revenue, $585–$605 million adjusted EBITDA, and $2.00–$2.15 adjusted diluted EPS. Q3 results reflected a 63% decline in COVID-19 revenue and continued wind-down of the U.S. Donor Screening portfolio.

#QDEL QuidelOrtho Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/QDEL/quidel-ortho-r...

QuidelOrtho to Present at the Baird 2025 Global Healthcare Conference QuidelOrtho Corporation will engage in a fireside chat at the Baird 2025 Global Healthcare Conference, showcasing its innovative diagnostics solutions.

QuidelOrtho to Present at the Baird 2025 Global Healthcare Conference #diagnostics #QuidelOrtho #QDEL

QuidelOrtho Earnings: Labs Growth and $100M Cost Savings Boost EBITDA Despite Revenue Headwinds QuidelOrtho delivers 330bps EBITDA margin improvement and hits $100M cost savings target. Labs segment grows 4%. See full Q2 2025 performance details.

#QDEL QuidelOrtho Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/QDEL/quidel-ortho-r...

Leading Indicators, Tuesday July 29, 2025 – Crystal Equity Research

Small-cap stocks in new downtrend with AROON Oscillator, Tue Jul 29th - #PBYI #QDEL #REAX #SEAT #SPWR #TBLA #XPEL #DOGZ #ECPG #FCEL #GEOS #HLIT #IDN #JAMF #KE #MITK #NEO #CRMT #BNRG #ADEA #ZIP #XPER #ONTF #HIPO - More: crystalequityresearch.com/leading-indi... - #smallcap

Emergency Drug Detection: How New Diagnostic Tests Are Saving Lives in Overdose Crisis Discover how rapid diagnostic testing transforms emergency overdose response amid rising fentanyl and polydrug threats. Critical insights for emergency care teams. Learn more.

#QDEL Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

www.stocktitan.net/news/QDEL/urgent-need-fo...

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics QuidelOrtho (QDEL) announced a strategic shift in its molecular diagnostics business, planning to acquire LEX Diagnostics for approximately $100 million upon FDA clearance while discontinuing its Savanna platform development. LEX Diagnostics' innovative platform delivers rapid molecular test results, with positive results for Flu A, Flu B, and COVID-19 in about 6 minutes and negative results in 10 minutes. The company expects FDA 510(k) clearance in late 2025 or early 2026. This strategic decision follows QuidelOrtho's comprehensive review under CEO Brian J. Blaser to drive shareholder value. The company maintains its fiscal 2025 financial guidance previously announced on February 12, 2025.

#QDEL QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

www.stocktitan.net/news/QDEL/quidel-ortho-a...

QuidelOrtho Reports First Quarter 2025 Financial Results QuidelOrtho (QDEL) reported Q1 2025 financial results with total revenue of $693 million, showing 5% growth as reported and 6% in constant currency, excluding COVID-19 and Donor Screening. The company's Labs revenue grew 5% as reported, while non-respiratory revenue remained flat at $573 million. GAAP operating margin improved significantly from -247% to 5%, and adjusted EBITDA margin increased by 450 basis points to 23%. The company reported a GAAP net loss of $13 million ($0.19 per share), compared to a $1.71 billion loss in the prior year period. Cost-saving initiatives drove improved profitability with GAAP operating expenses decreasing by 9%. QuidelOrtho maintained its full-year 2025 guidance, projecting total revenues of $2.60-$2.81 billion and adjusted EBITDA of $575-$615 million.

#QDEL QuidelOrtho Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/QDEL/quidel-ortho-r...

You Asked: QDEL replacing OLED? The end of 55″ & 65″ TVs? On today’s You Asked: USB-C instead of HDMI on TVs? What’s the latest on QDEL? Can AVRs damage your picture quality?

You Asked: QDEL replacing OLED? The end of 55″ & 65″ TVs? #Technology #Hardware #Other #QDEL #OLED #Televisions

Kako tehnologija brzo napreduje, ovo je uživanje gledati 📺 #QDEL ↔️ #OLED

benchmark.rs/vesti/nauka-...

QuidelOrtho Earnings Reveal $2.03B Loss, Sets Bold Recovery Plan for 2025 QuidelOrtho reports Q4 revenue decline to $708M, with respiratory sales down 18%. Company projects 2025 revenue of $2.60-2.81B amid strategic restructuring.

#QDEL QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

www.stocktitan.net/news/QDEL/quidel-ortho-r...

QuidelOrtho Q4 Revenue Preview Hits $707M Target, Shows Strong Non-Respiratory Growth QuidelOrtho reports preliminary Q4 revenue of $702-707M, with robust non-respiratory segment reaching $563M. Results align with company guidance amid transformation initiatives.

#QDEL QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

www.stocktitan.net/news/QDEL/quidel-ortho-a...

#QDEL QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

www.stocktitan.net/news/QDEL/quidel-ortho-c...

#QDEL QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

www.stocktitan.net/news/QDEL/quidel-ortho-c...

TCL CSOT zeigt echtes QLED-Laptop und verspricht 1 Million US-Dollar für das Haltbarkeitsproblem blauer QLEDs Für funktionierende QLED-Displays muss die Haltbarkeit blauer QLEDs verlängert werden. TCL CSOT verspricht deswegen ein Preisgeld über das "Blue Star Project" von einer Million US-Dollar für blaue QLE...

Ich hätte nicht gedacht, dass ich auf der Display Week bereits ein so gut funktionierendes Notebook-Display auf (echter) QLED-Basis sehen würde. Die blauen QLEDs von TCL halten auch eine ganze Weile.

#displayweek24 #displayweek2024 #tclcsot #QLED #QDEL

www.notebookcheck.com/TCL-CSOT-zei...

Meet QDEL, the backlight-less display tech that could replace OLED in premium TVs Interested in gadgets with premium displays? QDEL should be on your radar.

Meet #QDEL, the backlight-less display tech that could replace #OLED in premium TVs | #hardware #TV #tech #technology | arstechnica.com/gadgets/2024...